Judgment of the General Court of 11 February 2020 — Dalasa v EUIPO — Charité — Universitätsmedizin Berlin (charantea)

(Case T-732/18) (1)

(EU trade mark - Opposition proceedings - Application for EU word mark charantea - Earlier EU figurative mark CHARITÉ - Relative ground for refusal - No likelihood of confusion - Article 8(1)(b) of Regulation (EU) 2017/1001)

(2020/C 95/32)

Language of the case: German

Parties

Applicant: Dalasa Handelsgesellschaft mbH (Vienna, Austria) (represented by: I. Hödl, lawyer)

Defendant: European Union Intellectual Property Office (represented by: A. Söder, acting as Agent)

Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court: Charité — Universitätsmedizin Berlin, Gliedkörperschaft Öffentlichen Rechts (Berlin, Germany) (represented by: A. Wulff and K. Schmidt-Hern, lawyers)

Re:

Action brought against the decision of the Fourth Board of Appeal of EUIPO of 15 October 2018 (Case R 539/2018-4) relating to opposition proceedings between Charité and Dalasa.

Operative part of the judgment

The Court:

1.	Annuls the decision of the Fourth Board of Appeal of the European Union Intellectual Property Office (EUIPO) of 15 October 2018 (Case R 539/2018-4);

2.	Orders EUIPO to bear its own costs and to pay those incurred by Dalasa Handelsgesellschaft mbH in the proceedings before the General Court;

3.	Orders Charité — Universitätsmedizin Berlin, Gliedkörperschaft Öffentlichen Rechts to bear the costs that it has incurred during the proceedings before the General Court;

4.	Dismisses the action as to the remainder.

---

(1)  OJ C 54, 11.2.2019.